OXALIPLATIN HOSPIRA 5 mg/ml (100mg) Solution injectable pour perfusion
Country: Tunisia
Language: French
Source: Ministère de la Santé, Direction de l'inspection Pharmaceutique
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
OXALIPLATINE
Available from:
HOSPIRA UK Limited
INN (International Name):
OXALIPLATINE
Dosage:
5 mg/ml (100mg)
Pharmaceutical form:
Solution injectable pour perfusion
Units in package:
B/1 flacon/20 ml
Class:
A
Therapeutic group:
ANTINEOPLASIQUES
Therapeutic area:
ANTINEOPLASIQUES ET IMMUNOMODULATEURS
Therapeutic indications:
L'oxaliplatine en association avec le 5-fluorouracile et l'acide folinique est indiqué dans: - le traitement adjuvant du cancer du colon au stade III (stade C de Dukes) après résection complète de la tumeur initiale - le traitement des cancers colorectaux métastatiques.
Product summary:
Classement VEIC: Vital
Authorization date:
2010-07-19
